Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Hutchmed (China) Limited 29 December 2023 Blocklisting Six Monthly Return Hong Kong, Shanghai, & Florham Park, NJ - Friday, December 29, 2023: HUTCHMED (China) Limited (" HUTCHMED "...
Hutchmed (China) Limited 29 December 2023 Total Voting Rights Hong Kong, Shanghai, & Florham Park, NJ -- Friday, December 29, 2023: HUTCHMED (China) Limited ("HUTCHMED"...
Hutchmed (China) Limited 21 December 2023 Overseas Regulatory Announcement - Continuing Connected Transactions HUTCHMED (China) Limited (" HUTCHMED ") notes the below text, which is...
Hutchmed (China) Limited 07 December 2023 Overseas Regulatory Announcement - Disposal of Interest in Consumer Products Businesses HUTCHMED (China) Limited ("HUTCHMED") notes the below...
Hutchmed (China) Limited 30 November 2023 Total Voting Rights Hong Kong, Shanghai, & Florham Park, NJ -- Thursday, November 30, 2023: HUTCHMED (China) Limited ("HUTCHMED"...
Hutchmed (China) Limited 09 November 2023 HUTCHMED Announces that Takeda Receives U.S. FDA Approval of FRUZAQLA(TM) (fruquintinib) for Previously Treated Metastatic Colorectal Cancer - FRUZAQLA...
Hutchmed (China) Limited 24 October 2023 Vesting of awards under the Long Term Incentive Plan Hong Kong, Shanghai & Florham Park, NJ - Tuesday, October 24, 2023: HUTCHMED (China) Limited...
Hutchmed (China) Limited 29 September 2023 Total Voting Rights Hong Kong, Shanghai, & Florham Park, NJ -- Friday, September 29, 2023: HUTCHMED (China) Limited ("HUTCHMED"...
Hutchmed (China) Limited 14 September 2023 Director's Share Dealing Hong Kong, Shanghai & Florham Park, NJ - Thursday, September 14, 2023: HUTCHMED (China) Limited (" HUTCHMED...
Hutchmed (China) Limited 31 August 2023 Total Voting Rights Hong Kong, Shanghai, & Florham Park, NJ -- Thursday, August 31, 2023: HUTCHMED (China) Limited ("HUTCHMED") (Nasdaq/AIM:...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -12 | -4.93827160494 | 243 | 256.34 | 225 | 2276 | 252.19514981 | DE |
| 4 | -14 | -5.71428571429 | 245 | 256.34 | 225 | 2347 | 243.59623413 | DE |
| 12 | -74 | -24.262295082 | 305 | 326.97 | 225 | 2506 | 269.66261731 | DE |
| 26 | -69 | -23 | 300 | 327.3 | 225 | 3885 | 279.67827019 | DE |
| 52 | -29 | -11.1538461538 | 260 | 350.14 | 178 | 3365 | 283.99573959 | DE |
| 156 | -212.5 | -47.9143179256 | 443.5 | 476.5 | 132.5394 | 4247 | 259.12281124 | DE |
| 260 | -174 | -42.962962963 | 405 | 634 | 132.5394 | 5608 | 354.58374296 | DE |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
